Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression Profiling in Ovarian Cancer Reveals Coordinated Regulation of BRCA1/2 and Homologous Recombination Genes. | Biomedicines | 2022 | 35203410 | PubTator, text mining | PubMed |
| NBS1-CtIP-mediated DNA end resection suppresses cGAS binding to micronuclei. | Nucleic Acids Res | 2022 | 35189637 | PubTator, text mining | PubMed |
| Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib. | NPJ Breast Cancer | 2022 | 35181666 | PubTator, text mining | PubMed |
| Retracted Article: LncRNA KCNQ1OT1 Promotes Apoptosis and Oxidative Stress of Human Lens Epithelial Cells through Epigenetic Regulation of WRN. | Curr Eye Res | 2022 | 35179402 | PubTator, text mining | PubMed |
| Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition. | Cancer Med | 2022 | 35174967 | PubTator, text mining | PubMed |
| R-Loop-Associated Genomic Instability and Implication of WRN and WRNIP1. | Int J Mol Sci | 2022 | 35163467 | PubTator, text mining | PubMed |
| PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers. | Cancers (Basel) | 2022 | 35158866 | PubTator, text mining | PubMed |
| Cancer Genomic Alterations Can Be Potential Biomarkers Predicting Microvascular Invasion and Early Recurrence of Hepatocellular Carcinoma. | Front Oncol | 2022 | 35155229 | PubTator, text mining | PubMed |
| Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions. | Microvasc Res | 2022 | 35143811 | PubTator, text mining | PubMed |
| Transcriptomic Analysis Reveals the Messenger RNAs Responsible for the Progression of Alcoholic Cirrhosis. | Hepatol Commun | 2022 | 35134262 | PubTator, text mining | PubMed |
| Targeted Cancer Therapy Based on Acetylation and Deacetylation of Key Proteins Involved in Double-Strand Break Repair. | Cancer Manag Res | 2022 | 35115826 | PubTator, text mining | PubMed |
| Structure-based prediction of HDAC6 substrates validated by enzymatic assay reveals determinants of promiscuity and detects new potential substrates. | Sci Rep | 2022 | 35110592 | PubTator, text mining | PubMed |
| Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families. | PLoS One | 2022 | 35085295 | PubTator, text mining | PubMed |
| Neurofibromin and suppression of tumorigenesis: beyond the GAP. | Oncogene | 2022 | 35066574 | PubTator, text mining | PubMed |
| CRISPR-based genome editing through the lens of DNA repair. | Mol Cell | 2022 | 35063100 | PubTator, text mining | PubMed |
| Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities. | Cancers (Basel) | 2022 | 35053509 | PubTator, text mining | PubMed |
| Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology. | Cancer Treat Rev | 2022 | 35051883 | PubTator, text mining | PubMed |
| Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with Chemoradiotherapy. | Onco Targets Ther | 2022 | 35046666 | PubTator, text mining | PubMed |
| Deciphering the mechanism of processive ssDNA digestion by the Dna2-RPA ensemble. | Nat Commun | 2022 | 35042867 | PubTator, text mining | PubMed |
| RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1. | J Clin Invest | 2022 | 35025765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=34